| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $24.26B | $23.03B | $21.73B |
| YoY Revenue Growth % | +5.3% | +6.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.15B | $4.32B | $4.02B |
| Operating Margin % | 21.2% | 18.8% | 18.5% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $11.97B | $10.00B | $4.81B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.25B | $5.57B | $4.70B |
| Capital Expenditures (CapEx) | $8.53B | $7.10B | $977.7M |
| Free Cash Flow (FCF) | -$2.27B | -$1.53B | $3.73B |
| FCF Margin % | -9.4% | -6.6% | 17.1% |
| Return on Invested Capital (ROIC %) | 5.4% | 4.9% | 20.2% |
| Cash & Short-Term Equivalents | $626.0M | $357.0M | — |
| Total Debt (Short + Long Term) | $47.41B | $42.95B | $6.10B |
| Total Stockholders' Equity | $28.80B | $26.92B | $12.51B |